{
    "hands_on_practices": [
        {
            "introduction": "Successful rectal cancer surgery hinges on meticulous preoperative planning. This practice problem focuses on the crucial step of translating diagnostic imaging into a concrete surgical plan. By calculating the limiting safety margin from hypothetical MRI data, you will practice balancing the oncologic necessities of adequate distal and radial margins with the functional goal of sphincter preservation, a core challenge in transanal surgery. ",
            "id": "4680341",
            "problem": "A patient with low rectal adenocarcinoma has undergone Magnetic Resonance Imaging (MRI) for preoperative planning of TransAnal Minimally Invasive Surgery (TAMIS) and TransAnal Total Mesorectal Excision (TaTME). On MRI, the tumor’s distal-most extent is measured along the rectal axis to be $14\\,\\mathrm{mm}$ proximal to the puborectalis sling, which defines the anorectal ring. The shortest circumferential distance from the tumor to the mesorectal fascia is measured to be $1.8\\,\\mathrm{mm}$ at the $7$ o’clock position.\n\nUse the following widely accepted oncologic principles:\n- After neoadjuvant therapy, the minimal distal margin required for oncologic adequacy is $10\\,\\mathrm{mm}$.\n- The Circumferential Radial Margin (CRM) is considered oncologically adequate when the tumor is strictly more than $1\\,\\mathrm{mm}$ from the mesorectal fascia; a CRM is considered threatened when it is at or below $1\\,\\mathrm{mm}$.\n\nAssume the distal transection during TAMIS must be performed proximal to the puborectalis sling to preserve sphincter function, and that TaTME dissection follows the mesorectal fascial plane circumferentially. Define the limiting safety margin $F$ (in millimeters) as the lesser of:\n1. The surplus distance available beyond the required distal margin above the puborectalis sling, and\n2. The surplus distance beyond the minimal CRM requirement.\n\nCompute $F$ based on the provided measurements. Express your final answer in millimeters and round your result to four significant figures.",
            "solution": "The user has provided a problem that requires validation before a solution can be attempted.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\n- The distal-most extent of the tumor is measured to be $d_{\\text{tumor}} = 14\\,\\mathrm{mm}$ proximal to the puborectalis sling.\n- The shortest circumferential distance from the tumor to the mesorectal fascia (Circumferential Radial Margin, CRM) is $d_{\\text{CRM}} = 1.8\\,\\mathrm{mm}$.\n- The minimal required distal margin for oncologic adequacy is $m_{\\text{distal,req}} = 10\\,\\mathrm{mm}$.\n- The minimal CRM for oncologic adequacy is defined as being strictly more than $1\\,\\mathrm{mm}$, which establishes the threshold at $m_{\\text{CRM,req}} = 1\\,\\mathrm{mm}$.\n- The limiting safety margin, $F$, is defined as the lesser of two quantities:\n  1. The surplus distance available beyond the required distal margin.\n  2. The surplus distance beyond the minimal CRM requirement.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientifically Grounded:** The problem is grounded in established principles of surgical oncology, specifically the preoperative assessment for rectal cancer surgery (TAMIS/TaTME). The parameters (distal margin, CRM) and their oncologic thresholds are standard in clinical practice. The provided numerical values are realistic.\n- **Well-Posed:** The problem is well-posed. It provides all necessary data and a clear, unambiguous definition for the quantity $F$ to be calculated. A unique solution exists.\n- **Objective:** The problem is stated in objective, clinical language, free of bias or subjective claims.\n\n**Step 3: Verdict and Action**\n- **Verdict:** The problem is deemed valid.\n- **Action:** Proceed with the solution.\n\n### Solution\n\nThe objective is to compute the limiting safety margin, $F$, which is defined as the lesser of two distinct surplus margins: the surplus distal margin ($S_{\\text{distal}}$) and the surplus circumferential radial margin ($S_{\\text{CRM}}$).\n\nFirst, we calculate the surplus distal margin, $S_{\\text{distal}}$. This is the amount of tissue available for resection between the tumor's distal edge and the puborectalis sling, beyond what is strictly required for the oncologic margin.\n\nThe tumor's distal edge is located at a distance of $d_{\\text{tumor}} = 14\\,\\mathrm{mm}$ from the puborectalis sling. The required distal margin is $m_{\\text{distal,req}} = 10\\,\\mathrm{mm}$. The surplus is the difference between the available distance and the required distance.\n\n$$S_{\\text{distal}} = d_{\\text{tumor}} - m_{\\text{distal,req}}$$\n$$S_{\\text{distal}} = 14\\,\\mathrm{mm} - 10\\,\\mathrm{mm} = 4\\,\\mathrm{mm}$$\n\nSecond, we calculate the surplus circumferential radial margin, $S_{\\text{CRM}}$. This represents how much the measured CRM exceeds the minimum threshold for being considered oncologically safe.\n\nThe measured CRM is $d_{\\text{CRM}} = 1.8\\,\\mathrm{mm}$. The problem states that the margin is adequate if it is strictly more than $1\\,\\mathrm{mm}$. Therefore, the minimum requirement threshold is $m_{\\text{CRM,req}} = 1\\,\\mathrm{mm}$. The surplus is the difference between the measured margin and this threshold.\n\n$$S_{\\text{CRM}} = d_{\\text{CRM}} - m_{\\text{CRM,req}}$$\n$$S_{\\text{CRM}} = 1.8\\,\\mathrm{mm} - 1\\,\\mathrm{mm} = 0.8\\,\\mathrm{mm}$$\n\nFinally, the limiting safety margin, $F$, is defined as the lesser of these two surplus values. This identifies the most constrained dimension of the planned resection.\n\n$$F = \\min(S_{\\text{distal}}, S_{\\text{CRM}})$$\n$$F = \\min(4\\,\\mathrm{mm}, 0.8\\,\\mathrm{mm})$$\n$$F = 0.8\\,\\mathrm{mm}$$\n\nThe problem requires the final answer to be rounded to four significant figures. The calculated value is $0.8$. To express this with four significant figures, we write it as $0.8000$.",
            "answer": "$$\\boxed{0.8000}$$"
        },
        {
            "introduction": "Beyond planning the oncologic resection, surgeons must anticipate and mitigate potential complications based on patient-specific risk factors. This exercise moves beyond intuition to a structured, quantitative analysis of a complex clinical decision: whether to create a diverting loop ileostomy. By using an expected utility model and calculating the net benefit in Quality-Adjusted Life Days (QALDs), you will learn to formally weigh the reduced impact of a potential anastomotic leak against the definite morbidity of a stoma, a powerful framework for personalized surgical judgment. ",
            "id": "4680319",
            "problem": "A patient with distal rectal adenocarcinoma is scheduled for Transanal Total Mesorectal Excision (TaTME), which is part of the broader transanal minimally invasive rectal surgery spectrum that includes Transanal Minimally Invasive Surgery (TAMIS). The patient has been on systemic corticosteroids (prednisone equivalent) at an average dose of $10\\,\\mathrm{mg/day}$ for $8$ weeks and has Type $2$ diabetes mellitus with glycated hemoglobin of $0.072$. Consider an anastomosis created at the ultra-low rectum. Your decision is whether to construct a diverting loop ileostomy at the time of TaTME.\n\nUse a first-principles expected utility framework in quality-adjusted life days (QALDs) in the early postoperative period (from the index operation to stoma reversal or equivalent recovery), with the following scientifically plausible inputs:\n\n- Baseline probability of a clinically significant anastomotic leak after TaTME without diversion is $p_{0} = 0.10$.\n- The presence of systemic corticosteroids increases the probability of clinical leak by a multiplicative factor $m_{s} = 1.5$; the presence of diabetes increases it by $m_{d} = 1.3$. Treat these multipliers as independent and multiplicative for the clinical leak probability.\n- A diverting loop ileostomy reduces the probability of a clinical leak event by a factor $r_{d} = 0.55$ relative to the patient’s individualized (steroid- and diabetes-adjusted) leak probability. In the diverted arm, leaks that do occur have reduced average severity.\n- Quality-adjusted life day losses:\n  - If no diversion is used and a clinical leak occurs, the expected loss is $L = 40$ QALDs per leak event.\n  - If diversion is used and a clinical leak occurs, the expected loss is $L_{d} = 24$ QALDs per leak event.\n  - Living with the ileostomy until reversal incurs an average disutility of $0.02$ QALDs per day, and the planned interval to reversal is $90$ days; treat this as a deterministic loss.\n  - Diversion-specific morbidities: dehydration requiring readmission occurs with probability $p_{h} = 0.12$ and causes an expected loss of $D = 3$ QALDs per event; stoma-specific complications (e.g., high-output, peristomal skin issues requiring interventions) occur with probability $p_{c} = 0.08$ and cause an expected loss of $C = 5$ QALDs per event.\n  - Stoma reversal surgery causes an expected loss of $R = 2$ QALDs and is achieved in this patient with probability $p_{r} = 0.95$ within the modeled interval.\n\nAssume event probabilities are independent within each strategy, and restrict your analysis to the early postoperative period as defined. Using these inputs and starting from the expected utility principle (maximize expected QALDs, equivalently minimize expected QALD losses), compute the net expected QALD benefit of constructing a diverting ileostomy compared to not constructing one, defined as the expected QALD losses without diversion minus the expected QALD losses with diversion. Based on the sign of this net benefit, state whether diversion is recommended (yes/no) and provide a brief rationale tied to the calculation.\n\nExpress the final net expected benefit in QALDs and round your numerical result to four significant figures. Use decimal probabilities (do not use the percentage sign).",
            "solution": "The fundamental base is the expected utility framework, where the expected utility in quality-adjusted life days (QALDs) is maximized by minimizing expected QALD losses across uncertain outcomes. We construct two strategies: without diversion and with diversion, and compute the expected QALD loss for each. The net benefit of diversion is defined as the expected QALD losses without diversion minus the expected QALD losses with diversion. A positive net benefit indicates that diversion reduces expected QALD losses and is therefore favored.\n\nStep 1: Compute the individualized clinical leak probability without diversion. The baseline probability is $p_{0} = 0.10$. Steroids and diabetes act as multiplicative risk factors with $m_{s} = 1.5$ and $m_{d} = 1.3$, respectively. Thus,\n$$\np_{\\text{leak, no div}} = p_{0} \\times m_{s} \\times m_{d} = 0.10 \\times 1.5 \\times 1.3 = 0.195.\n$$\n\nStep 2: Compute the expected QALD loss without diversion. If a clinical leak occurs without diversion, the expected loss is $L = 40$ QALDs per event. Therefore, the expected loss in the no-diversion arm is\n$$\nE[\\text{loss} \\mid \\text{no div}] = p_{\\text{leak, no div}} \\times L = 0.195 \\times 40 = 7.8.\n$$\n\nStep 3: Compute the clinical leak probability with diversion. Diversion reduces the probability of clinical leak by a factor $r_{d} = 0.55$ applied to the individualized leak probability:\n$$\np_{\\text{leak, div}} = r_{d} \\times p_{\\text{leak, no div}} = 0.55 \\times 0.195 = 0.10725.\n$$\n\nStep 4: Compute the expected QALD loss due to leaks with diversion. When a leak occurs with diversion, the expected loss is reduced to $L_{d} = 24$ QALDs per event, thus\n$$\nE[\\text{leak loss} \\mid \\text{div}] = p_{\\text{leak, div}} \\times L_{d} = 0.10725 \\times 24 = 2.574.\n$$\n\nStep 5: Compute additional expected losses specific to diversion.\n\n- Deterministic disutility of living with a stoma until reversal over $90$ days at $0.02$ QALDs per day:\n$$\nS = 90 \\times 0.02 = 1.8.\n$$\n\n- Dehydration readmission expected loss:\n$$\nE[\\text{dehydration loss}] = p_{h} \\times D = 0.12 \\times 3 = 0.36.\n$$\n\n- Stoma complication expected loss:\n$$\nE[\\text{stoma complication loss}] = p_{c} \\times C = 0.08 \\times 5 = 0.4.\n$$\n\n- Reversal surgery expected loss:\n$$\nE[\\text{reversal loss}] = p_{r} \\times R = 0.95 \\times 2 = 1.9.\n$$\n\nStep 6: Sum the expected losses in the diversion arm:\n$$\nE[\\text{loss} \\mid \\text{div}] = E[\\text{leak loss} \\mid \\text{div}] + S + E[\\text{dehydration loss}] + E[\\text{stoma complication loss}] + E[\\text{reversal loss}],\n$$\n$$\nE[\\text{loss} \\mid \\text{div}] = 2.574 + 1.8 + 0.36 + 0.4 + 1.9 = 7.034.\n$$\n\nStep 7: Compute the net expected QALD benefit of diversion compared to no diversion, defined as the expected QALD losses without diversion minus the expected QALD losses with diversion:\n$$\n\\Delta = E[\\text{loss} \\mid \\text{no div}] - E[\\text{loss} \\mid \\text{div}] = 7.8 - 7.034 = 0.766.\n$$\n\nInterpretation and recommendation: Since $\\Delta = 0.766$ QALDs (rounded to four significant figures as $0.7660$) is positive, constructing a diverting loop ileostomy decreases expected QALD losses in the early postoperative period for this steroid- and diabetes-exposed patient undergoing TaTME. Therefore, diversion is recommended. The rationale is that although diversion introduces stoma-related disutility and complications, it reduces both the probability and average severity of clinically significant leaks sufficiently that the net expected QALD impact favors diversion in this high-risk profile.\n\nRounded final net expected benefit (QALDs): $0.7660$.",
            "answer": "$$\\boxed{0.7660}$$"
        },
        {
            "introduction": "The surgeon's work continues long after the final suture; quality assessment is essential for improving practice and predicting patient outcomes. The macroscopic quality of the resected Total Mesorectal Excision (TME) specimen serves as a direct measure of surgical precision and is a powerful predictor of local recurrence. This final practice problem closes the feedback loop from planning to execution by asking you to apply standardized grading criteria to a described surgical specimen, connecting technical proficiency directly to long-term oncologic prognosis. ",
            "id": "4680300",
            "problem": "A patient with mid-rectal adenocarcinoma (clinical stage cT3N1) undergoes Transanal Total Mesorectal Excision (TaTME), a form of Transanal Minimally Invasive Surgery (TAMIS) adapted to perform Total Mesorectal Excision (TME) from a transanal approach. The fresh specimen is photographed before fixation. The photograph depicts the posterior and lateral mesorectal surfaces and the distal taper. The following features are noted by the operating surgeon and pathologist jointly at the bench:\n\n1) The outer mesorectal envelope is irregular, with multiple surface defects. The largest measured defect is $12\\,\\mathrm{mm}$ deep, and India ink placed on the surface tracks directly onto visible circular muscle fibers of the rectal muscularis propria within this defect.\n\n2) In two quadrants, there are crater-like defects greater than $5\\,\\mathrm{mm}$ in diameter, with clear exposure of the muscularis propria; in several other areas there are smaller scalloped irregularities.\n\n3) The distal $3\\,\\mathrm{cm}$ of the specimen shows obvious “coning,” with abrupt narrowing of the mesorectal bulk and a cuff of exposed circular muscle circumferentially. There is no frank perforation into the rectal lumen, and the tumor is not visible at the inked surface.\n\n4) The distal donut from the stapled transection is intact.\n\nFor purposes of risk stratification, define the $5$-year local recurrence probability $P_{\\mathrm{LR}}$ and categorize it as follows: low if $P_{\\mathrm{LR}} < 0.10$, intermediate if $0.10 \\le P_{\\mathrm{LR}} \\le 0.20$, and high if $P_{\\mathrm{LR}} > 0.20$, assuming a negative circumferential resection margin and equivalent nodal clearance.\n\nBased on accepted mesorectal grading criteria for TME specimen quality, choose the single best pairing of mesorectal grade and $P_{\\mathrm{LR}}$ category for this photographed specimen.\n\nA. Complete mesorectal excision (good) with low $P_{\\mathrm{LR}}$.\n\nB. Near-complete mesorectal excision (intermediate) with intermediate $P_{\\mathrm{LR}}$.\n\nC. Incomplete mesorectal excision (poor) with high $P_{\\mathrm{LR}}$.\n\nD. Near-complete mesorectal excision (intermediate) with low $P_{\\mathrm{LR}}$.\n\nE. Complete mesorectal excision (good) with intermediate $P_{\\mathrm{LR}}$.",
            "solution": "### Problem Validation\n\n**Step 1: Extract Givens**\n- **Procedure:** Transanal Total Mesorectal Excision (TaTME) for mid-rectal adenocarcinoma.\n- **Clinical Stage:** cT$3$N$1$.\n- **Specimen Features:**\n    1. Irregular mesorectal envelope with a defect of $12$ $\\mathrm{mm}$ depth, tracking to the rectal muscularis propria.\n    2. Two crater-like defects > $5$ $\\mathrm{mm}$ in diameter with exposure of the muscularis propria.\n    3. Distal $3$ $\\mathrm{cm}$ of the specimen exhibits \"coning\" with a circumferential cuff of exposed circular muscle.\n    4. No frank perforation into the rectal lumen.\n    5. Tumor is not visible at the inked surface.\n    6. Distal donut from stapled transection is intact.\n- **Definitions:**\n    - Local Recurrence Probability: $P_{\\mathrm{LR}}$.\n    - Low Risk: $P_{\\mathrm{LR}} < 0.10$.\n    - Intermediate Risk: $0.10 \\le P_{\\mathrm{LR}} \\le 0.20$.\n    - High Risk: $P_{\\mathrm{LR}} > 0.20$.\n- **Assumptions:** For the purpose of risk stratification, a negative circumferential resection margin (CRM) and equivalent nodal clearance are assumed.\n- **Question:** Determine the mesorectal grade and corresponding $P_{\\mathrm{LR}}$ category.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientific Grounding:** The problem is scientifically sound. The classification of Total Mesorectal Excision (TME) specimen quality is a standard, evidence-based practice in surgical pathology for rectal cancer. The criteria described (specimen integrity, depth of defects, exposure of muscularis propria, coning) are the established parameters for this grading. The correlation between TME specimen quality and local recurrence rates is a fundamental principle in modern rectal cancer management, supported by extensive clinical research.\n- **Well-Posed:** The problem provides a detailed, objective description of a surgical specimen and explicit definitions for risk categorization. The assumptions are clearly stated to isolate the variable of interest (TME plane quality). This structure allows for a unique and meaningful solution based on established medical knowledge.\n- **Objectivity:** The language used is precise and objective, employing standard terminology from pathology and surgery (e.g., \"muscularis propria,\" \"coning,\" \"mesorectal envelope\"). The quantitative data ($12$ $\\mathrm{mm}$, $5$ $\\mathrm{mm}$, $3$ $\\mathrm{cm}$) are clear and unambiguous.\n\n**Step 3: Verdict and Action**\nThe problem statement is scientifically grounded, well-posed, and objective. It presents a realistic clinical scenario that can be evaluated using established principles of surgical pathology. The problem is **VALID**.\n\n### Solution Derivation\n\nThe solution requires a two-step analysis: first, grading the TME specimen based on its macroscopic features, and second, correlating this grade with the defined probability of local recurrence ($P_{\\mathrm{LR}}$).\n\n**1. Mesorectal Excision Grade Assessment**\n\nThe quality of a TME specimen is most commonly graded using the criteria developed by Quirke and colleagues, which classifies specimens into three categories:\n\n- **Complete (Good):** The specimen has a smooth, intact mesorectal envelope with a glistening surface. Defects are minimal and superficial (depth $ 5\\,\\mathrm{mm}$). There is no exposure of the rectal wall's muscularis propria. The specimen has a regular, cylindrical or conical shape with substantial mesorectal bulk.\n- **Near-complete (Intermediate):** The mesorectal envelope is moderately bulky but shows some irregularity. Defects in the mesorectal fat are present, with depths $> 5\\,\\mathrm{mm}$, but they do not extend down to the muscularis propria of the rectum.\n- **Incomplete (Poor):** The mesorectal envelope is substantially disrupted, with little bulk. There are deep defects that extend down to the muscularis propria, exposing the rectal muscle wall. A characteristic feature is \"coning\" of the distal specimen, where the mesorectal tissue is absent, leaving an exposed cuff of muscle.\n\nApplying these criteria to the specimen described:\n- **Feature 1:** A defect depth of $12$ $\\mathrm{mm}$ decisively excludes the specimen from the \"Complete\" category. The fact that ink tracks \"directly onto visible circular muscle fibers of the rectal muscularis propria\" is a defining characteristic of an \"Incomplete\" TME.\n- **Feature 2:** \"Crater-like defects greater than $5$ $\\mathrm{mm}$ in diameter, with clear exposure of the muscularis propria\" further substantiates a grade of \"Incomplete.\" Exposure of the underlying muscle signifies a surgical dissection that has strayed from the correct embryological plane (the \"holy plane\") and entered the rectal wall itself.\n- **Feature 3:** The presence of \"obvious 'coning,' with abrupt narrowing of the mesorectal bulk and a cuff of exposed circular muscle circumferentially\" is the archetypal feature of a poor quality, \"Incomplete\" distal resection.\n\nBased on the confluence of these three definitive features—defects extending to the muscularis propria and distal coning—the specimen must be classified as **Incomplete mesorectal excision (poor)**.\n\n**2. Local Recurrence Probability ($P_{\\mathrm{LR}}$) Categorization**\n\nThe quality of the TME surgery is a powerful independent predictor of local recurrence. The problem asks for the $P_{\\mathrm{LR}}$ category assuming a negative CRM. This isolates the prognostic impact of the surgical plane itself. Leaving microscopic disease foci in the patient due to a poor surgical plane is the mechanism for increased local recurrence even with a tumor-free margin on the specimen.\n\n- **Complete TME:** This is the goal of surgery and is associated with the lowest rates of local recurrence. In the modern era, this corresponds to a $5$-year $P_{\\mathrm{LR}}$ well below $10\\%$. This fits the **low** risk category ($P_{\\mathrm{LR}}  0.10$).\n- **Near-complete TME:** This denotes a suboptimal but not disastrous surgery. It is associated with a higher local recurrence rate than a complete TME. This risk would typically fall into the **intermediate** category ($0.10 \\le P_{\\mathrm{LR}} \\le 0.20$).\n- **Incomplete TME:** This represents a surgical failure. The likelihood of leaving residual disease in the pelvis is high, leading to a markedly increased rate of local recurrence. Numerous studies have shown that an incomplete TME is associated with $5$-year local recurrence rates that are two to four times higher than a complete TME, frequently exceeding $20\\%-30\\%$. This grade corresponds to the **high** risk category ($P_{\\mathrm{LR}}  0.20$).\n\nGiven the specimen is graded as Incomplete (poor), the associated risk of local recurrence is **high**.\n\n**Conclusion:** The specimen represents an Incomplete mesorectal excision (poor) and is associated with a high $P_{\\mathrm{LR}}$ category.\n\n### Option-by-Option Analysis\n\n**A. Complete mesorectal excision (good) with low $P_{\\mathrm{LR}}$.**\n- **Mesorectal grade:** Incorrect. The specimen features (deep defects to muscle, coning) are the opposite of a complete excision.\n- **$P_{\\mathrm{LR}}$ category:** Incorrect. The risk associated with this specimen is high, not low.\n- **Verdict:** Incorrect.\n\n**B. Near-complete mesorectal excision (intermediate) with intermediate $P_{\\mathrm{LR}}$.**\n- **Mesorectal grade:** Incorrect. The defects extend to the muscularis propria, which classifies the specimen as incomplete, not near-complete.\n- **$P_{\\mathrm{LR}}$ category:** Incorrect. The risk is high, not intermediate.\n- **Verdict:** Incorrect.\n\n**C. Incomplete mesorectal excision (poor) with high $P_{\\mathrm{LR}}$.**\n- **Mesorectal grade:** Correct. The description of deep defects extending to the muscularis propria and distal coning are the defining features of an incomplete (poor) TME.\n- **$P_{\\mathrm{LR}}$ category:** Correct. An incomplete TME is strongly and independently correlated with a high risk of local recurrence ($P_{\\mathrm{LR}}  0.20$).\n- **Verdict:** Correct.\n\n**D. Near-complete mesorectal excision (intermediate) with low $P_{\\mathrm{LR}}$.**\n- **Mesorectal grade:** Incorrect. The grade is incomplete.\n- **$P_{\\mathrm{LR}}$ category:** Incorrect. The risk is high, not low. Furthermore, a near-complete excision would typically be associated with intermediate, not low, risk, making the pairing itself inconsistent.\n- **Verdict:** Incorrect.\n\n**E. Complete mesorectal excision (good) with intermediate $P_{\\mathrm{LR}}$.**\n- **Mesorectal grade:** Incorrect. The grade is incomplete.\n- **$P_{\\mathrm{LR}}$ category:** Incorrect. A complete excision is associated with low, not intermediate, risk, making the pairing inconsistent.\n- **Verdict:** Incorrect.",
            "answer": "$$\\boxed{C}$$"
        }
    ]
}